These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10686184)

  • 1. The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis.
    Ebers GC; Koopman WJ; Hader W; Sadovnick AD; Kremenchutzky M; Mandalfino P; Wingerchuk DM; Baskerville J; Rice GP
    Brain; 2000 Mar; 123 Pt 3():641-9. PubMed ID: 10686184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of multiple sclerosis.
    Ebers GC
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71 Suppl 2(Suppl 2):ii16-9. PubMed ID: 11701779
    [No Abstract]   [Full Text] [Related]  

  • 4. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
    Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC
    Brain; 2010 Jul; 133(Pt 7):1914-29. PubMed ID: 20534650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
    Kremenchutzky M; Cottrell D; Rice G; Hader W; Baskerville J; Koopman W; Ebers GC
    Brain; 1999 Oct; 122 ( Pt 10)():1941-50. PubMed ID: 10506095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
    Kerbrat A; Hamonic S; Leray E; Tron I; Edan G; Yaouanq J;
    Eur J Neurol; 2015 Mar; 22(3):507-e35. PubMed ID: 25515927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early relapses, onset of progression, and late outcome in multiple sclerosis.
    Scalfari A; Neuhaus A; Daumer M; Deluca GC; Muraro PA; Ebers GC
    JAMA Neurol; 2013 Feb; 70(2):214-22. PubMed ID: 23407713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: predicting risk and delaying progression.
    Yeh EA; Weinstock-Guttman B
    Lancet Neurol; 2010 Jan; 9(1):7-9. PubMed ID: 20083024
    [No Abstract]   [Full Text] [Related]  

  • 11. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression in familial and nonfamilial MS.
    Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
    Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
    Lublin FD; Bowen JD; Huddlestone J; Kremenchutzky M; Carpenter A; Corboy JR; Freedman MS; Krupp L; Paulo C; Hariri RJ; Fischkoff SA
    Mult Scler Relat Disord; 2014 Nov; 3(6):696-704. PubMed ID: 25891548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis in sibling pairs: an analysis of 250 families.
    Chataway J; Mander A; Robertson N; Sawcer S; Deans J; Fraser M; Broadley S; Clayton D; Compston A
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):757-61. PubMed ID: 11723196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticipation of age at onset in familial multiple sclerosis.
    Romero-Pinel L; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Kremenchutzky M; Arbizu T
    Eur J Neurol; 2010 Apr; 17(4):572-5. PubMed ID: 20002735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.
    Siger-Zajdel M; Selmaj K
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):752-6. PubMed ID: 11723195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of patients with multiple sclerosis in West France.
    Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
    Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.
    Boles GS; Hillert J; Ramanujam R; Westerlind H; Olsson T; Kockum I; Manouchehrinia A
    Mult Scler; 2023 Sep; 29(10):1209-1215. PubMed ID: 37435869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.